{"metadata": {"source": "pubchem", "title": "Amphetamine | C9H13N | CID 3007 - PubChem", "description": "Amphetamine | C9H13N | CID 3007 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3007", "drug": "Amphetamine", "cid": 3007, "char_count": 163268, "word_count": 21396, "doc_id": "doc_3", "num_chunks": 220, "chunk_id": "3::chunk_67", "document_index": 3, "latency_s": 1.3661576000013156, "prompt_toks": 43058, "completion_toks": 74, "relevance_score": 1.0348532e-06}, "content": "Drug: Amphetamine | cid: 3007\nSource: pubchem | Source description: Amphetamine | C9H13N | CID 3007 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Use (kg) in USA (2002): 4820\n\nConsumption (g per capita) in the USA (2002): 0.0171\n\nCalculated removal (%): 75.5\n\nDOI:10.1021/acs.est.5b03332\n\nFor treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.\n\nUsed to treat attention deficit hyperactivity disorder (ADHD). Used as a psychostimulant drug. [Wikipedia]\n\n9.1.1 Use Classification\n\nHuman Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients\n\nPharmaceuticals -> Anaesthetics -> Transformation products\n\nS66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448\n\nPharmaceuticals\n\nS72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664\n\n9.2 Methods of Manufacturing\n\nAmphetamine is prepared by treating phenylacetone with formic acid and ammonia under the Leuckart-Wallach conditions.\n\n\n                    Context: \n                    This snippet summarizes key data on amphetamine's usage, including quantities in the USA in 2002, its application for ADHD and narcolepsy in children, along with manufacturing methods involving phenylacetone, and its classification within pharmaceutical and regulatory databases. It provides essential reference identifiers, usage statistics, and production details relevant to chemical, pharmacological, and regulatory research.\n                "}
{"metadata": {"source": "pubchem", "title": "Benzoylecgonine | C16H19NO4 | CID 448223 - PubChem", "description": "Benzoylecgonine | C16H19NO4 | CID 448223 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/448223", "drug": "Benzoylecgonine", "cid": 448223, "char_count": 22402, "word_count": 2383, "doc_id": "doc_1", "num_chunks": 28, "chunk_id": "1::chunk_21", "document_index": 1, "latency_s": 2.4090367000026163, "prompt_toks": 7534, "completion_toks": 96, "relevance_score": 9.4224464e-07}, "content": "Drug: Benzoylecgonine | cid: 448223\nSource: pubchem | Source description: Benzoylecgonine | C16H19NO4 | CID 448223 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://echa.europa.eu/web/guest/legal-notice\n\nO-benzoylecgonine\n\nhttps://echa.europa.eu/substance-information/-/substanceinfo/100.007.513\n\nO-benzoylecgonine (EC: 208-263-5)\n\nhttps://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/31293\n\nFDA Global Substance Registration System (GSRS)\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nBENZOYLECGONINE\n\nhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/5353I8I6YS\n\nCCSbase\n\nCCSbase Classification\n\nhttps://ccsbase.net/\n\nNORMAN Suspect List Exchange\n\nLICENSE\n\nData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0\n\n\n                    Context: \n                    This chunk provides regulatory and licensing information for benzoylecgonine, including links to legal notices from the European Chemicals Agency (ECHA), FDA Global Substance Registration System (GSRS), and classification resources like CCSbase and the NORMAN Suspect List Exchange. It highlights official chemical registry entries and licensing terms relevant to chemical safety, public domain usage, and data sharing, supporting the document’s comprehensive coverage of benzoylecgonine’s identification and regulatory status.\n                "}
{"metadata": {"source": "psychonaut", "title": "LSD - PsychonautWiki", "description": "Lysergic acid diethylamide (also known as Lysergide, LSD-25, LSD, L, Lucy, and Acid) is a classical psychedelic substance of the lysergamide class.[2] It is perhaps the most researched and culturally influential psychedelic substance, as well as the prototypal lysergamide. The mechanism of action is not fully known, although serotonin binding activity is thought to be involved.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/LSD", "drug": "LSD", "cid": 5761, "char_count": 85077, "word_count": 12291, "doc_id": "doc_85", "num_chunks": 107, "chunk_id": "85::chunk_61", "document_index": 85, "latency_s": 1.013629299995955, "prompt_toks": 22381, "completion_toks": 73, "relevance_score": 8.9209925e-07}, "content": "Drug: LSD | cid: 5761\nSource: psychonaut | Source description: Lysergic acid diethylamide (also known as Lysergide, LSD-25, LSD, L, Lucy, and Acid) is a classical psychedelic substance of the lysergamide class.[2] It is perhaps the most researched and culturally influential psychedelic substance, as well as the prototypal lysergamide. The mechanism of action is not fully known, although serotonin binding activity is thought to be involved.\n\n                    Text: \n                    Ernst Jünger, German writer and philosopher, throughout his life had experimented with substances such as ether, cocaine, and hashish; and later in life he used mescaline and LSD. These experiments were recorded comprehensively in Annäherungen (1970, Approaches). The novel Visit to Godenholm|Besuch auf Godenholm (1952, Visit to Godenholm) is clearly influenced by his early experiments with mescaline and LSD. He met with LSD inventor Albert Hofmann and they took LSD together several times.[83] He is the inventor of the term \"psychonaut\".\n\n\n                    Context: \n                    This section provides information on notable individuals’ experiences with LSD, highlighting Ernst Jünger’s experiments with substances including LSD, his influence on literature, and his collaboration with inventor Albert Hofmann. It emphasizes Jünger’s role in early psychedelic exploration and his invention of the term \"psychonaut,\" relevant for understanding LSD’s cultural and historical significance discussed throughout the document.\n                "}
